Navigation Links
JCR, Hill-Rom Launch Nurse Safety Scholar-in-Residence Program
Date:1/9/2009

OAK BROOK, Ill. and BATESVILLE, Ind., Jan. 9 /PRNewswire-FirstCall/ -- Recognizing the important role nurses play in translating evidence-based findings to excellent care at the patient's bedside, Joint Commission Resources (JCR) and Hill-Rom (NYSE: HRC), are collaborating to launch a Nurse Safety Scholar-in-Residence program in 2009. JCR is a not-for-profit affiliate of The Joint Commission. Hill-Rom is a global medical technology company.

The Nurse Safety Scholar-in-Residence program will focus initially on developing tools and best practices to maintain skin integrity and prevent pressure ulcers. An estimated 2.5 million patients are treated for pressure ulcers in acute care facilities in the United States each year, according to studies published in the Journal of the American Medical Association in 2003 and 2006. In the future, expert nurse clinicians and scholars in the program will concentrate on putting into practice evidence-based solutions to prevent patient falls. Both pressure ulcers and in-hospital falls are among the preventable conditions and events on Medicare's "no pay" list.

"Nurses play a role in all patient safety efforts and this scholar-in- residence program will give nursing leaders an opportunity to develop and share innovative solutions to these significant patient safety problems," says Deborah Nadzam, Ph.D., F.A.A.N., practice leader, Patient Safety, JCR.

"At Hill-Rom we strive to use our resources in ways that make a difference every day in the lives of patients and their caregivers," says Melissa Fitzpatrick, R.N., M.S.N., F.A.A.N., vice president and chief clinical officer for Hill-Rom. "We see collaborating with JCR in this important research as one key way to support the discovery of new solutions to truly enhance the safety and ultimate positive outcomes for patients. Collaborating with a world-class organization such as JCR enables us to accomplish patient safety goals that neither of us would be able to accomplish on our own."

    The goals of the program are:

    -- Fostering the professional development of expert nurse clinicians and
       scholars to become translators of evidence into practice;

    -- Identifying best practice processes and technology associated with
       providing safe care for specific clinical problems; and

    -- Establishing hospital collaborative projects focused on clinical
       challenges and adverse events, initially relating to skin care and the
       prevention of falls.

The selected nurse will serve a twelve-month appointment as Scholar-in- Residence and, in addition to other project responsibilities, will:

    -- Receive training in patient safety and performance measurement and
       improvement;

    -- Author a manuscript for submission to a refereed journal;

    -- Participate in the selection of hospitals participating in the project;
       and

    -- Coordinate the activities of participating hospitals and educate their
       staff regarding the performance improvement model and best practices
       for the prevention of harm.

The program will be managed through JCR. Applicants are now being sought for the scholar-in-residence program. The deadline for applications is February 23, with the first scholars being announced in April 2009. For more information about the program or to apply, please visit http://www.jcrinc.com/JCR-Hill-Rom-Nurse-Scholar/.

About Joint Commission Resources

Joint Commission Resources, Inc. (JCR), a not-for-profit affiliate of The Joint Commission, has been designated by The Joint Commission to publish publications and multimedia products. JCR reproduces and distributes these materials under license from The Joint Commission. JCR educational programs and publications support the accreditation activities of The Joint Commission, but are separate functions. Attendees at JCR educational programs and purchasers of JCR publications receive no special consideration or treatment in, or confidential information about, the accreditation process. Learn more about Joint Commission Resources at www.jcrinc.com.

About Hill-Rom

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom ... enhancing outcomes for patients and their caregivers.


'/>"/>
SOURCE Hill-Rom
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hill-Rom Announces First Quarter 2009 Dividend
2. Hill-Rom Wins Gold Brandon Hall Learning Award
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast
4. Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames
5. Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year
6. Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast
7. Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities
8. Hill-Rom to Present at the Jefferies Healthcare Conference
9. Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award
10. Hill-Rom Announces Third Quarter 2008 Dividend
11. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Hamlin ... to announce that they are sponsoring a raffle. Throughout the month of February, patients ... will receive a gift card for a dinner for two at the Cheesecake Factory. ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... “Doping in Sport: How the Culture Might Change,” in conjunction with ... symposium will be held at Pepperdine University in Malibu, California. , Sir Philip ...
(Date:2/23/2017)... PHILADELPHIA (PRWEB) , ... February 23, 2017 , ... ... risk and uncertainty in clinical trials, today announced that Premier Research, a leading ... management solution. , Clinical trials are becoming increasingly complex, due in part to ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and ... children with autism spectrum disorder (ASD) to see films in an environment that ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... her Smiling Patriot program today with a new Indiegogo campaign . ... care to homeless veterans in the Los Angeles area, either as a participating patient ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 LG Innotek today announced that the company ... As its sterilization performance is 1.5 times higher than the competitor,s ... rays in the range of 200 -- 280nm, allowing it to be ... destroying their DNA. LG Innotek,s product emits UV in the range ... Until ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Cardiac Prosthetic Devices Market is ... next decade to reach approximately $8.9 billion by 2025. ... the given segments on global as well as regional levels presented ...
(Date:2/23/2017)... February 23, 2017 Tillotts Pharma ... Berlin office was opened in ... . The portfolio includes Entocort ® for the ... treatment of ulcerative colitis, and VistaPrep ® for ... Swiss specialty pharmaceutical company focused on the treatment of ...
Breaking Medicine Technology: